Skip to main content
Top

03-02-2025 | Human Immunodeficiency Virus | Original Paper

Pilot Trial of a Transdiagnostic Cognitive Behavioral Therapy (CBT)-Based Group Intervention to Reduce Psychological Distress, Facilitate Positive Behavior Change, and Mitigate Inflammation in Older People with HIV

Authors: Jacklyn D. Foley, Madison Davis, Stephanie Schiavo, Lauren Bernier, Shibani S. Mukerji, Abigail W. Batchelder

Published in: AIDS and Behavior

Login to get access

Abstract

More than half of adults with HIV in the United States are aged 50 or older. Older people with HIV (OPWH) are disproportionately affected by age-related health disparities and non-communicable diseases associated with inflammation. The current pilot randomized controlled trial (RCT) evaluated the feasibility and acceptability, while exploring signals of effects of a transdiagnostic cognitive behavioral therapy (CBT) modular group teaching skills to cope with distress, make positive health behavior changes, and ultimately reduce inflammation. Participants were 31 virally undetectable, and psychiatrically stable OPWH (age \(\:\ge\:\)50 years). Participants were randomized 1:1 to enhanced usual care or CBT for HIV and Symptom Management (CHAMP). CHAMP consists of 12-weekly virtual group sessions led by two interventionists. Self-report questionnaires and intravenous blood draws were collected at baseline and follow-up. Intervention participants completed an exit interview. Of those screened eligible, 96.8% (30/31) were randomized (n = 15 per group), 86.7% (13/15) completed the intervention, and 87% (26/30) completed the follow-up. On acceptability questionnaires scaled 0–3, participants reported high satisfaction and the intervention to be of high quality (M(SD)=3.00(0.0) for both). They also indicated their needs were met (2.67(0.50)) and coping improved (2.60(0.52)). Intervention participants showed a mean decrease in anxiety (-1.07(6.08)) and depressive (-1.71(5.37)) symptoms on clinical screeners, and mean increase in quality of life (2.86(3.59)). CHAMP is both feasible and acceptable for OPWH. Exploratory analyses indicate favorable outcomes for improving psychological distress and health-related quality of life.
Literature
1.
go back to reference Centers for Disease Control and, Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016, in HIV Surveillance Supplemental Report. 2019. Centers for Disease Control and, Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016, in HIV Surveillance Supplemental Report. 2019.
2.
go back to reference Samji H, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.PubMedPubMedCentralCrossRef Samji H, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.PubMedPubMedCentralCrossRef
3.
go back to reference Trickey A, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–56.CrossRef Trickey A, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–56.CrossRef
4.
go back to reference High KP, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60(Suppl 1):S1–18.PubMedCrossRef High KP, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60(Suppl 1):S1–18.PubMedCrossRef
5.
go back to reference Guaraldi G, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–6.PubMedCrossRef Guaraldi G, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–6.PubMedCrossRef
6.
go back to reference Schouten J, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–97.PubMedCrossRef Schouten J, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–97.PubMedCrossRef
8.
go back to reference Losina E, et al. Projecting 10-year, 20-year, and lifetime risks of cardiovascular disease in persons living with human immunodeficiency virus in the United States. Clin Infect Dis. 2017;65(8):1266–71.PubMedPubMedCentralCrossRef Losina E, et al. Projecting 10-year, 20-year, and lifetime risks of cardiovascular disease in persons living with human immunodeficiency virus in the United States. Clin Infect Dis. 2017;65(8):1266–71.PubMedPubMedCentralCrossRef
9.
go back to reference Lorenz DR, et al. Predictors of transition to frailty in middle-aged and older people with HIV: a prospective cohort study. JAIDS J Acquir Immune Defic Syndr. 2021;88(5):518–27.PubMedCrossRef Lorenz DR, et al. Predictors of transition to frailty in middle-aged and older people with HIV: a prospective cohort study. JAIDS J Acquir Immune Defic Syndr. 2021;88(5):518–27.PubMedCrossRef
10.
go back to reference Bruguera A, et al. Predictors of poor health-related quality of life among people living with HIV aged ≥ 60 years in the PISCIS cohort: findings from the vive + project. HIV Med. 2024;25(4):424–39.PubMedCrossRef Bruguera A, et al. Predictors of poor health-related quality of life among people living with HIV aged ≥ 60 years in the PISCIS cohort: findings from the vive + project. HIV Med. 2024;25(4):424–39.PubMedCrossRef
11.
go back to reference Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Oxford University Press; 2011;53(11):1127–9. Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Oxford University Press; 2011;53(11):1127–9.
12.
go back to reference Luetkens JA, et al. Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imaging. 2016;9(3):e004091.PubMedCrossRef Luetkens JA, et al. Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imaging. 2016;9(3):e004091.PubMedCrossRef
14.
go back to reference Bastard J-P, et al. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity. J Antimicrob Chemother. 2015;70(6):1816–24.PubMedCrossRef Bastard J-P, et al. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity. J Antimicrob Chemother. 2015;70(6):1816–24.PubMedCrossRef
15.
go back to reference Freeman ML, et al. CD8 T-cell expansion and inflammation linked to CMV coinfection in ART-treated HIV infection. Clin Infect Dis. 2016;62(3):392–6.PubMedCrossRef Freeman ML, et al. CD8 T-cell expansion and inflammation linked to CMV coinfection in ART-treated HIV infection. Clin Infect Dis. 2016;62(3):392–6.PubMedCrossRef
17.
go back to reference Chung HY, et al. Redefining chronic inflammation in aging and age-related diseases: proposal of the Senoinflammation Concept. Aging Dis. 2019;10(2):367–82.PubMedPubMedCentralCrossRef Chung HY, et al. Redefining chronic inflammation in aging and age-related diseases: proposal of the Senoinflammation Concept. Aging Dis. 2019;10(2):367–82.PubMedPubMedCentralCrossRef
18.
go back to reference Gabuzda D, et al. Pathogenesis of aging and age-related comorbidities in people with HIV: highlights from the HIV ACTION workshop. Pathogens Immun. 2020;5(1):143.CrossRef Gabuzda D, et al. Pathogenesis of aging and age-related comorbidities in people with HIV: highlights from the HIV ACTION workshop. Pathogens Immun. 2020;5(1):143.CrossRef
19.
go back to reference Masters MC, et al. Chronic HIV infection and aging: application of a geroscience-guided approach. JAIDS J Acquir Immune Defic Syndr. 2022;89(S1):S34–46.PubMedCrossRef Masters MC, et al. Chronic HIV infection and aging: application of a geroscience-guided approach. JAIDS J Acquir Immune Defic Syndr. 2022;89(S1):S34–46.PubMedCrossRef
20.
go back to reference Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54(3):295–306.PubMedCrossRef Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54(3):295–306.PubMedCrossRef
21.
go back to reference Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.PubMedCrossRef Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.PubMedCrossRef
22.
23.
go back to reference O’Cleirigh C, Hart TA, James CA. HIV and anxiety. Anxiety in health behaviors and physical illness, 2008: pp. 317–340. O’Cleirigh C, Hart TA, James CA. HIV and anxiety. Anxiety in health behaviors and physical illness, 2008: pp. 317–340.
24.
go back to reference O’Donovan A, et al. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion–biology relationships. Behav Immun. 2010;24(7):1074–7.CrossRef O’Donovan A, et al. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion–biology relationships. Behav Immun. 2010;24(7):1074–7.CrossRef
25.
go back to reference Pitsavos C, et al. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis. 2006;185(2):320–6.PubMedCrossRef Pitsavos C, et al. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis. 2006;185(2):320–6.PubMedCrossRef
26.
go back to reference Howren MB, Lamkin DM, Suls J. Associations of Depression with C-Reactive protein, IL-1, and IL-6: a Meta-analysis. Psychosom Med, 2009; 71(2). Howren MB, Lamkin DM, Suls J. Associations of Depression with C-Reactive protein, IL-1, and IL-6: a Meta-analysis. Psychosom Med, 2009; 71(2).
27.
go back to reference Rayanakorn A, et al. Predictors of Stigma and Health-Related Quality of Life among People Living with HIV in Northern Thailand. AIDS Patient Care STDS. 2022;36(5):186–93.PubMedPubMedCentralCrossRef Rayanakorn A, et al. Predictors of Stigma and Health-Related Quality of Life among People Living with HIV in Northern Thailand. AIDS Patient Care STDS. 2022;36(5):186–93.PubMedPubMedCentralCrossRef
28.
go back to reference Degroote S, Vogelaers D, Vandijck DM. What determines health-related quality of life among people living with HIV: an updated review of the literature. Arch Public Health. 2014;72(1):40.PubMedPubMedCentralCrossRef Degroote S, Vogelaers D, Vandijck DM. What determines health-related quality of life among people living with HIV: an updated review of the literature. Arch Public Health. 2014;72(1):40.PubMedPubMedCentralCrossRef
29.
30.
go back to reference Bayes-Marin I et al. Determinants of depressive symptoms in people living with HIV: findings from a Population-based study with a gender perspective. Int J Environ Res Public Health, 2023; 20(4). Bayes-Marin I et al. Determinants of depressive symptoms in people living with HIV: findings from a Population-based study with a gender perspective. Int J Environ Res Public Health, 2023; 20(4).
31.
go back to reference Wertz J, et al. Association of history of psychopathology with accelerated aging at midlife. JAMA Psychiatry. 2021;78(5):530–9.PubMedCrossRef Wertz J, et al. Association of history of psychopathology with accelerated aging at midlife. JAMA Psychiatry. 2021;78(5):530–9.PubMedCrossRef
32.
go back to reference Richmond-Rakerd LS, et al. Longitudinal associations of Mental disorders with Physical diseases and Mortality among 2.3 million New Zealand citizens. JAMA Netw Open. 2021;4(1):e2033448–2033448.PubMedPubMedCentralCrossRef Richmond-Rakerd LS, et al. Longitudinal associations of Mental disorders with Physical diseases and Mortality among 2.3 million New Zealand citizens. JAMA Netw Open. 2021;4(1):e2033448–2033448.PubMedPubMedCentralCrossRef
33.
go back to reference Braithwaite RS, et al. Do Alcohol Misuse, Smoking, and Depression Vary Concordantly or sequentially? A longitudinal study of HIV-Infected and matched uninfected veterans in Care. AIDS Behav. 2016;20(3):566–72.PubMedPubMedCentralCrossRef Braithwaite RS, et al. Do Alcohol Misuse, Smoking, and Depression Vary Concordantly or sequentially? A longitudinal study of HIV-Infected and matched uninfected veterans in Care. AIDS Behav. 2016;20(3):566–72.PubMedPubMedCentralCrossRef
34.
go back to reference Jamali F, et al. Correlation between Daily Dietary micronutrients Intake and Mental Health outcomes in iranians living with HIV infection. J Assoc Nurses AIDS Care. 2016;27(6):817–25.PubMedCrossRef Jamali F, et al. Correlation between Daily Dietary micronutrients Intake and Mental Health outcomes in iranians living with HIV infection. J Assoc Nurses AIDS Care. 2016;27(6):817–25.PubMedCrossRef
35.
go back to reference Isaac R, et al. Declines in dietary macronutrient intake in persons with HIV infection who develop depression. Public Health Nutr. 2008;11(2):124–31.PubMedCrossRef Isaac R, et al. Declines in dietary macronutrient intake in persons with HIV infection who develop depression. Public Health Nutr. 2008;11(2):124–31.PubMedCrossRef
36.
go back to reference Thai TT, et al. The association between symptoms of mental disorders and health risk behaviours in Vietnamese HIV positive outpatients: a cross-sectional study. BMC Public Health. 2017;17(1):1–12.CrossRef Thai TT, et al. The association between symptoms of mental disorders and health risk behaviours in Vietnamese HIV positive outpatients: a cross-sectional study. BMC Public Health. 2017;17(1):1–12.CrossRef
37.
go back to reference Safren SA, et al. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Lancet HIV. 2016;3(11):e529–38.PubMedPubMedCentralCrossRef Safren SA, et al. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Lancet HIV. 2016;3(11):e529–38.PubMedPubMedCentralCrossRef
38.
go back to reference Safren SA, Otto MW, Worth JL. Life-steps: applying cognitive behavioral therapy to HIV medication adherence. Cogn Behav Pract. 1999;6(4):332–41.CrossRef Safren SA, Otto MW, Worth JL. Life-steps: applying cognitive behavioral therapy to HIV medication adherence. Cogn Behav Pract. 1999;6(4):332–41.CrossRef
39.
go back to reference Magidson JF, et al. Implementing behavioral activation and life-steps for Depression and HIV Medication Adherence in a Community Health Center. Cogn Behav Pract. 2014;21(4):386–403.PubMedPubMedCentralCrossRef Magidson JF, et al. Implementing behavioral activation and life-steps for Depression and HIV Medication Adherence in a Community Health Center. Cogn Behav Pract. 2014;21(4):386–403.PubMedPubMedCentralCrossRef
40.
go back to reference Pu H, et al. Systematic review of cognitive behavior therapy to improve mental health of women living with HIV. J Investig Med. 2020;68(1):30–6.PubMedCrossRef Pu H, et al. Systematic review of cognitive behavior therapy to improve mental health of women living with HIV. J Investig Med. 2020;68(1):30–6.PubMedCrossRef
41.
go back to reference Shi Y, et al. Effects of cognitive behavioral therapy on people living with HIV and depression: a systematic review and meta-analysis. Psychol Health Med. 2019;24(5):578–94.PubMedCrossRef Shi Y, et al. Effects of cognitive behavioral therapy on people living with HIV and depression: a systematic review and meta-analysis. Psychol Health Med. 2019;24(5):578–94.PubMedCrossRef
42.
go back to reference Scott-Sheldon LAJ, et al. Mindfulness-based interventions for adults living with HIV/AIDS: a systematic review and Meta-analysis. AIDS Behav. 2019;23(1):60–75.PubMedPubMedCentralCrossRef Scott-Sheldon LAJ, et al. Mindfulness-based interventions for adults living with HIV/AIDS: a systematic review and Meta-analysis. AIDS Behav. 2019;23(1):60–75.PubMedPubMedCentralCrossRef
43.
go back to reference Foley JD, et al. Evaluation of a newly developed Transdiagnostic Cognitive Behavioral Therapy Group to promote healthy aging among older people with HIV: study protocol for a pilot randomized controlled trial. Open Access J Clin Trials. 2024;16(null):11–21.CrossRef Foley JD, et al. Evaluation of a newly developed Transdiagnostic Cognitive Behavioral Therapy Group to promote healthy aging among older people with HIV: study protocol for a pilot randomized controlled trial. Open Access J Clin Trials. 2024;16(null):11–21.CrossRef
44.
45.
go back to reference Totton N, et al. A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020. Pilot Feasibility Stud. 2023;9(1):188.PubMedPubMedCentralCrossRef Totton N, et al. A review of sample sizes for UK pilot and feasibility studies on the ISRCTN registry from 2013 to 2020. Pilot Feasibility Stud. 2023;9(1):188.PubMedPubMedCentralCrossRef
46.
go back to reference Sheehan DV et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20): 22–33. Sheehan DV et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20): 22–33.
47.
go back to reference Batchelder AW, et al. A novel technology-enhanced internalized stigma and shame intervention for HIV-positive persons with substance use disorders. Cogn Behav Pract. 2020;27(1):55–69.PubMedCrossRef Batchelder AW, et al. A novel technology-enhanced internalized stigma and shame intervention for HIV-positive persons with substance use disorders. Cogn Behav Pract. 2020;27(1):55–69.PubMedCrossRef
48.
go back to reference Acosta MC, et al. Web-delivered CBT reduces Heavy drinking in OEF-OIF veterans in Primary Care with Symptomatic Substance Use and PTSD. Behav Ther. 2017;48(2):262–76.PubMedCrossRef Acosta MC, et al. Web-delivered CBT reduces Heavy drinking in OEF-OIF veterans in Primary Care with Symptomatic Substance Use and PTSD. Behav Ther. 2017;48(2):262–76.PubMedCrossRef
49.
go back to reference Cohen S, Kamarck T, Mermelstein R. Perceived stress scale. Measuring Stress: Guide Health Social Scientists. 1994;10:1–2. Cohen S, Kamarck T, Mermelstein R. Perceived stress scale. Measuring Stress: Guide Health Social Scientists. 1994;10:1–2.
50.
go back to reference Pakenham K, Rinaldis M. Development of the HIV/AIDS stress scale. Psychol Health. 2002;17(2):203–19.CrossRef Pakenham K, Rinaldis M. Development of the HIV/AIDS stress scale. Psychol Health. 2002;17(2):203–19.CrossRef
52.
go back to reference Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef
53.
go back to reference Plummer F, et al. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31.PubMedCrossRef Plummer F, et al. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31.PubMedCrossRef
54.
go back to reference Heatherton TF, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.PubMedCrossRef Heatherton TF, et al. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.PubMedCrossRef
55.
go back to reference Selin KH. Test-retest reliability of the alcohol use disorder identification test in a general population sample. Alcoholism: Clin Experimental Res. 2003;27(9):1428–35.CrossRef Selin KH. Test-retest reliability of the alcohol use disorder identification test in a general population sample. Alcoholism: Clin Experimental Res. 2003;27(9):1428–35.CrossRef
56.
go back to reference Fowles JR, et al. A pilot study: validity and reliability of the CSEP-PATH PASB-Q and a new leisure time physical activity questionnaire to assess physical activity and sedentary behaviours. Appl Physiol Nutr Metab. 2017;42(6):677–80.PubMedCrossRef Fowles JR, et al. A pilot study: validity and reliability of the CSEP-PATH PASB-Q and a new leisure time physical activity questionnaire to assess physical activity and sedentary behaviours. Appl Physiol Nutr Metab. 2017;42(6):677–80.PubMedCrossRef
57.
go back to reference Conlin PR. The dietary approaches to stop hypertension (DASH) clinical trial: implications for lifestyle modifications in the treatment of hypertensive patients. Cardiol Rev. 1999;7(5):284–8.PubMedCrossRef Conlin PR. The dietary approaches to stop hypertension (DASH) clinical trial: implications for lifestyle modifications in the treatment of hypertensive patients. Cardiol Rev. 1999;7(5):284–8.PubMedCrossRef
58.
go back to reference Ware J Jr., Kosinski M, Keller SD. A 12-Item short-form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.PubMedCrossRef Ware J Jr., Kosinski M, Keller SD. A 12-Item short-form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.PubMedCrossRef
59.
go back to reference Blood Sampling Guidelines MG, Brigham E. 2023, Human Resource Affairs p. 3. Blood Sampling Guidelines MG, Brigham E. 2023, Human Resource Affairs p. 3.
60.
go back to reference Freedland KE. Pilot trials in health-related behavioral intervention research: problems, solutions, and recommendations. Health Psychol. 2020;39(10):851–62.PubMedCrossRef Freedland KE. Pilot trials in health-related behavioral intervention research: problems, solutions, and recommendations. Health Psychol. 2020;39(10):851–62.PubMedCrossRef
61.
go back to reference Version D. 9.0. 17, cloud application for managing, analyzing, and presenting qualitative and mixed methods research data (2021). Los Angeles, CA: SocioCultural Research Consultants, LLC. URL: www.dedoose. com, 2021. Version D. 9.0. 17, cloud application for managing, analyzing, and presenting qualitative and mixed methods research data (2021). Los Angeles, CA: SocioCultural Research Consultants, LLC. URL: www.dedoose. com, 2021.
62.
go back to reference Vaismoradi M et al. Theme development in qualitative content analysis and thematic analysis. J Nurs Educ Pract. 2016;6(5):100–110. Vaismoradi M et al. Theme development in qualitative content analysis and thematic analysis. J Nurs Educ Pract. 2016;6(5):100–110.
63.
go back to reference Zou H, et al. A mindfulness-oriented psycho-behavioral intervention for patients with acute coronary syndrome: a pilot study. Heart Lung. 2023;62:240–8.PubMedCrossRef Zou H, et al. A mindfulness-oriented psycho-behavioral intervention for patients with acute coronary syndrome: a pilot study. Heart Lung. 2023;62:240–8.PubMedCrossRef
64.
go back to reference O’Doherty V, et al. A controlled evaluation of mindfulness-based cognitive therapy for patients with coronary heart disease and depression. Mindfulness. 2015;6:405–16.CrossRef O’Doherty V, et al. A controlled evaluation of mindfulness-based cognitive therapy for patients with coronary heart disease and depression. Mindfulness. 2015;6:405–16.CrossRef
65.
go back to reference Zainal NH, Newman MG. A randomized controlled trial of a 14-day mindfulness ecological momentary intervention (MEMI) for generalized anxiety disorder. Eur Psychiatry. 2023;66(1):e12.PubMedPubMedCentralCrossRef Zainal NH, Newman MG. A randomized controlled trial of a 14-day mindfulness ecological momentary intervention (MEMI) for generalized anxiety disorder. Eur Psychiatry. 2023;66(1):e12.PubMedPubMedCentralCrossRef
66.
go back to reference Manzoor S, et al. Effectiveness of mobile health augmented cardiac rehabilitation on behavioural outcomes among post-acute coronary syndrome patients: a randomised controlled trial. J Coll Physicians Surg Pak. 2021;31(10):1148–53.PubMedCrossRef Manzoor S, et al. Effectiveness of mobile health augmented cardiac rehabilitation on behavioural outcomes among post-acute coronary syndrome patients: a randomised controlled trial. J Coll Physicians Surg Pak. 2021;31(10):1148–53.PubMedCrossRef
68.
go back to reference Koop MA, et al. Identifying the most important confounders when assessing the association between low-grade systemic inflammation and musculoskeletal pain: a modified Delphi study. Pain Med. 2021;22(11):2661–9.PubMedCrossRef Koop MA, et al. Identifying the most important confounders when assessing the association between low-grade systemic inflammation and musculoskeletal pain: a modified Delphi study. Pain Med. 2021;22(11):2661–9.PubMedCrossRef
69.
go back to reference Zucoloto ML, et al. Fear of blood, injections and fainting as barriers to blood donation in Brazil. Vox Sang. 2019;114(1):38–46.PubMedCrossRef Zucoloto ML, et al. Fear of blood, injections and fainting as barriers to blood donation in Brazil. Vox Sang. 2019;114(1):38–46.PubMedCrossRef
Metadata
Title
Pilot Trial of a Transdiagnostic Cognitive Behavioral Therapy (CBT)-Based Group Intervention to Reduce Psychological Distress, Facilitate Positive Behavior Change, and Mitigate Inflammation in Older People with HIV
Authors
Jacklyn D. Foley
Madison Davis
Stephanie Schiavo
Lauren Bernier
Shibani S. Mukerji
Abigail W. Batchelder
Publication date
03-02-2025
Publisher
Springer US
Published in
AIDS and Behavior
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-025-04647-5

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more